US Patent 7446106 Pyridylfurans and pyrroles as Raf kinase inhibitors

Patent 7446106 was granted and assigned to Smithkline Beecham Limited on November, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Smithkline Beecham Limited

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7446106

Date of Patent

November 4, 2008

Patent Application Number

10488577

Date Filed

September 5, 2002

Patent Primary Examiner

‌

Deepak Rao

Patent abstract

Compounds and their use as pharmaceuticals particularly as Raf kinase inhibitors for the treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7446106 Pyridylfurans and pyrroles as Raf kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API